Home/Filings/4/0001394548-17-000011
4//SEC Filing

Galena Biopharma, Inc. 4

Accession 0001394548-17-000011

$SLSCIK 0001390478operating

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 4:58 PM ET

Size

6.1 KB

Accession

0001394548-17-000011

Insider Transaction Report

Form 4
Period: 2017-02-06
Knapp Thomas J
General Counsel
Transactions
  • Award

    Stock Option (right to buy)

    2017-02-06+10,00010,000 total
    Exercise: $1.41Exp: 2027-02-06Common Stock (10,000 underlying)
Footnotes (2)
  • [F1]Granted pursuant to the Issuer's 2016 Incentive Plan.
  • [F2]This stock option will vest in equal, monthly installments over 8 months beginning May 1, 2017 through December 31, 2017, so long as the Reporting Person remains in the company's continuous employ through the vesting period.

Issuer

Galena Biopharma, Inc.

CIK 0001390478

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001390478

Filing Metadata

Form type
4
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 4:58 PM ET
Size
6.1 KB